MINNEAPOLIS & HONG KONG--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) and Shandong Weigao Group Medical Polymer Company Limited (Hong Kong Stock Exchange: 8199) (“Weigao”) today announced the completion of Medtronic’s equity investment in Weigao. As a result of the investment, Medtronic now holds a 15 percent equity stake in Weigao.
